Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study The ESPAC4 trial showed that adjuvant ...

Adjuvant radiation and endocrine therapy significantly reduce locoregional recurrence in early-stage breast cancer post-lumpectomy, especially in low-risk patients. Radiation therapy notably decreases ...

A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with stage III ...

A large observational analysis suggests that the presence of isolated tumor cells may signal worse survival in low-risk endometrial cancer.

Please provide your email address to receive an email when new articles are posted on . Daily aspirin use after adjuvant therapy did not improve outcomes for patients with colorectal cancer. Daily ...

Low-dose radiotherapy combined with neoadjuvant chemotherapy and an anti-PD-1/CTLA-4 bispecific antibody cardonilizumab for resectable locally advanced head and neck squamous cell carcinoma: ...

Breast cancer can return many years after the initial therapy. New long-term data bring hope for fewer relapses and better ...

Genetic assays have transformed how clinicians approach treatment decisions in breast cancer, offering both predictive and ...

Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in the Phase III clinical study ...

A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy.